Listed equity
Poly Medicure
पॉलि मेडिक्योर · પોલિ મેડિક્યોર
EOD close · 3 Sept 2026
The price is rising, but delivery data shows distribution underneath. Rallies without conviction can fade — watch the delivery numbers.
Now at 59% of its 52-week range
Last 30 sessions
+5.0%Phase indicator
Above 50- and 200-day MAs with +32.0% over 3 months — established uptrend.
Delivery conviction
Lifetime story
Poly Medicure is up 350020.0% from its lifetime low of ₹0.50 on 4 Jun 2003. ₹10,000 invested then would be worth ₹3,50,12,000 today (42.0% CAGR over 23.2 years). Lifetime high of ₹3350.00 was set on 1 Nov 2024 (currently -47.7% below).
30-day conviction trend
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM) | 53.32 | 56.89 |
| P/B | 5.71 | 5.62 |
| Price / Cash flow | 41.30 | 41.63 |
| Dividend yield | 0.20% | 0.20% |
| Book value / share | 309.86 ₹ | 314.70 ₹ |
| EPS (TTM) | 33.17 ₹ | 31.09 ₹ |
Returns ladder
How this page is produced
Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 3 Sept 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.
Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.
This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.